John Sarbanes actually said...

I think if you look at the impact on the public of drug prices, it is hard to argue that it isn't as extensive and permeating as those other...

Well, that is going to be subject to debate and whatever, but you are going to get a period of exclusivity.

I appreciate that. And it is obviously going to play itself out.

Basically Gilead is going to reap the benefit of two periods of exclusivity rather than one, correct?